WMSA
Weiss Multi-Strategy Advisers Portfolio holdings
AUM
$3.94B
1-Year Return
29.08%
This Quarter Return
+5.46%
1 Year Return
+29.08%
3 Year Return
+75.24%
5 Year Return
+223.81%
10 Year Return
+334.33%
AUM
$1.3B
AUM Growth
+$125M
(+11%)
Cap. Flow
+$70.8M
Cap. Flow
% of AUM
5.45%
Top 10 Holdings %
Top 10 Hldgs %
14.09%
Holding
510
New
118
Increased
99
Reduced
124
Closed
123
Top Buys
| 1 |
VRE
Veris Residential
VRE
|
$17.7M |
| 2 |
LPT
Liberty Property Trust
LPT
|
$17.6M |
| 3 |
Vornado Realty Trust
VNO
|
$16.6M |
| 4 |
Extra Space Storage
EXR
|
$16.5M |
| 5 |
Foot Locker
FL
|
$15.9M |
Top Sells
| 1 |
GGP
GGP Inc.
GGP
|
$29.8M |
| 2 |
SL Green Realty
SLG
|
$24.3M |
| 3 |
HPP
Hudson Pacific Properties
HPP
|
$21.9M |
| 4 |
PPS
Post Properties
PPS
|
$18.3M |
| 5 |
CSX Corp
CSX
|
$17M |
Sector Composition
| 1 | Real Estate | 20.96% |
| 2 | Consumer Discretionary | 16.6% |
| 3 | Industrials | 10.62% |
| 4 | Energy | 10.55% |
| 5 | Healthcare | 7.33% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
BLCM
301
DELISTED
Bellicum Pharmaceuticals, Inc.
BLCM
| $348K | 0.02% |
1,750
-73
| -4% | -$14.5K |
|
302
Navigator Holdings
NVGS
$1.11B
| $345K | 0.02% |
48,006
+12,725
| +36% | +$91.5K |
|
303
Teva Pharmaceuticals
TEVA
$21.7B
| $345K | 0.02% |
7,500
+210
| +3% | +$9.66K |
|
|
WMGI
304
DELISTED
Wright Medical Group Inc
WMGI
| $343K | 0.02% |
14,000
-580
| -4% | -$14.2K |
|
|
KERX
305
DELISTED
Keryx Biopharmaceuticals Inc
KERX
| $340K | 0.02% |
64,000
-1,610
| -2% | -$8.55K |
|
|
TRTN
306
DELISTED
Triton International Limited
TRTN
| $337K | 0.02% |
+25,554
| New | +$337K |
|
307
Exelixis
EXEL
$10.2B
| $333K | 0.02% |
26,000
+7,775
| +43% | +$99.6K |
|
|
HMSY
308
DELISTED
HMS Holdings Corp.
HMSY
| $333K | 0.02% |
15,000
-11,415
| -43% | -$253K |
|
|
ICPT
309
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $329K | 0.02% |
2,000
+177
| +10% | +$29.1K |
|
310
Curis
CRIS
$21M
| $324K | 0.02% |
1,240
-28
| -2% | -$7.32K |
|
|
HDS
311
DELISTED
HD Supply Holdings, Inc.
HDS
| $313K | 0.02% |
+9,798
| New | +$313K |
|
312
Pacira BioSciences
PCRX
$1.19B
| $305K | 0.02% |
+8,900
| New | +$305K |
|
|
MZOR
313
DELISTED
Mazor Robotics Ltd.
MZOR
| $298K | 0.02% |
11,500
-3,080
| -21% | -$79.8K |
|
|
OCRX
314
DELISTED
Ocera Therapeutics, Inc.
OCRX
| $290K | 0.02% |
110,000
-2,995
| -3% | -$7.9K |
|
315
Builders FirstSource
BLDR
$16.5B
| $288K | 0.02% |
25,000
-1,286
| -5% | -$14.8K |
|
316
Novartis
NVS
$251B
| $276K | 0.02% |
3,906
-162
| -4% | -$11.4K |
|
317
Rigel Pharmaceuticals
RIGL
$742M
| $275K | 0.02% |
7,500
-10,725
| -59% | -$393K |
|
318
Enanta Pharmaceuticals
ENTA
$189M
| $266K | 0.02% |
+10,000
| New | +$266K |
|
319
Xenon Pharmaceuticals
XENE
$3.02B
| $255K | 0.02% |
31,500
-900
| -3% | -$7.29K |
|
|
SPNC
320
DELISTED
Spectranetics Corp
SPNC
| $251K | 0.02% |
10,000
-935
| -9% | -$23.5K |
|
|
IMMU
321
DELISTED
Immunomedics Inc
IMMU
| $250K | 0.02% |
77,000
+4,100
| +6% | +$13.3K |
|
|
INSY
322
DELISTED
Insys Therapeutics, Inc.
INSY
| $248K | 0.02% |
21,000
-510
| -2% | -$6.02K |
|
323
Standard BioTools
LAB
$497M
| $240K | 0.01% |
30,000
+8,130
| +37% | +$65K |
|
|
MACK
324
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $235K | 0.01% |
4,703
+533
| +13% | +$26.6K |
|
325
TG Therapeutics
TGTX
$5.11B
| $232K | 0.01% |
30,000
-600
| -2% | -$4.64K |
|